Agenus announces strategic realignment to focus on core programs and significantly reduce costs

Lexington, mass.--(business wire)--agenus inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the advancement of its most impactful programs as it prepares for 2025. reductions are designed to reduce cash burn to $100 million in fy 2025. this initiative follows the successful closing of a $22 million mortgage secured by key real estate assets, providing the compan.
AGEN Ratings Summary
AGEN Quant Ranking